These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 34003005)
1. Structural Determinants of the Neuronal Glycine Transporter 2 for the Selective Inhibitors ALX1393 and ORG25543. Benito-Muñoz C; Perona A; Felipe R; Pérez-Siles G; Núñez E; Aragón C; López-Corcuera B ACS Chem Neurosci; 2021 Jun; 12(11):1860-1872. PubMed ID: 34003005 [TBL] [Abstract][Full Text] [Related]
2. Spinal antiallodynia action of glycine transporter inhibitors in neuropathic pain models in mice. Morita K; Motoyama N; Kitayama T; Morioka N; Kifune K; Dohi T J Pharmacol Exp Ther; 2008 Aug; 326(2):633-45. PubMed ID: 18448867 [TBL] [Abstract][Full Text] [Related]
3. Antinociceptive effect of intracerebroventricular administration of glycine transporter-2 inhibitor ALX1393 in rat models of inflammatory and neuropathic pain. Takahashi Y; Hara K; Haranishi Y; Terada T; Obara G; Sata T Pharmacol Biochem Behav; 2015 Mar; 130():46-52. PubMed ID: 25579325 [TBL] [Abstract][Full Text] [Related]
4. The antinociceptive effect of intrathecal administration of glycine transporter-2 inhibitor ALX1393 in a rat acute pain model. Haranishi Y; Hara K; Terada T; Nakamura S; Sata T Anesth Analg; 2010 Feb; 110(2):615-21. PubMed ID: 20081141 [TBL] [Abstract][Full Text] [Related]
5. ALX 1393 inhibits spontaneous network activity by inducing glycinergic tonic currents in the spinal ventral horn. Eckle VS; Antkowiak B Neuroscience; 2013 Dec; 253():165-71. PubMed ID: 23994185 [TBL] [Abstract][Full Text] [Related]
9. The efficacy of the analgesic GlyT2 inhibitor, ORG25543, is determined by two connected allosteric sites. Chater RC; Quinn AS; Wilson K; Frangos ZJ; Sutton P; Jayakumar S; Cioffi CL; O'Mara ML; Vandenberg RJ J Neurochem; 2023 Dec; ():. PubMed ID: 38131125 [TBL] [Abstract][Full Text] [Related]
10. Rescue of two trafficking-defective variants of the neuronal glycine transporter GlyT2 associated to hyperekplexia. de la Rocha-Muñoz A; Melgarejo E; Aragón C; López-Corcuera B Neuropharmacology; 2021 May; 189():108543. PubMed ID: 33794243 [TBL] [Abstract][Full Text] [Related]
11. Activity of novel lipid glycine transporter inhibitors on synaptic signalling in the dorsal horn of the spinal cord. Winters BL; Rawling T; Vandenberg RJ; Christie MJ; Bhola RF; Imlach WL Br J Pharmacol; 2018 Jun; 175(12):2337-2347. PubMed ID: 29500820 [TBL] [Abstract][Full Text] [Related]
12. P2X receptors up-regulate the cell-surface expression of the neuronal glycine transporter GlyT2. Villarejo-López L; Jiménez E; Bartolomé-Martín D; Zafra F; Lapunzina P; Aragón C; López-Corcuera B Neuropharmacology; 2017 Oct; 125():99-116. PubMed ID: 28734869 [TBL] [Abstract][Full Text] [Related]
13. Blockade of glycine transporter (GlyT) 2, but not GlyT1, ameliorates dynamic and static mechanical allodynia in mice with herpetic or postherpetic pain. Nishikawa Y; Sasaki A; Kuraishi Y J Pharmacol Sci; 2010; 112(3):352-60. PubMed ID: 20173309 [TBL] [Abstract][Full Text] [Related]
14. Identification of a 3rd Na+ Binding Site of the Glycine Transporter, GlyT2. Subramanian N; Scopelitti AJ; Carland JE; Ryan RM; O'Mara ML; Vandenberg RJ PLoS One; 2016; 11(6):e0157583. PubMed ID: 27337045 [TBL] [Abstract][Full Text] [Related]